Francesmary Modugno

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. ncbi Association of estrogen receptor alpha polymorphisms with breast cancer risk in older Caucasian women
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Int J Cancer 116:984-91. 2005
  2. ncbi Estrogen metabolizing polymorphisms and breast cancer risk among older white women
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, PA, USA
    Breast Cancer Res Treat 93:261-70. 2005
  3. ncbi Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 516A Parran Hall, 130 DeSoto Street, Pittsburgh, PA 15261, USA
    Int J Cancer 118:1292-301. 2006
  4. ncbi Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15261, USA
    Am J Obstet Gynecol 191:733-40. 2004
  5. ncbi Ovarian cancer and high-risk women-implications for prevention, screening, and early detection
    Francesmary Modugno
    Department of Epidemmiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Gynecol Oncol 91:15-31. 2003
  6. ncbi Inflammation and endometrial cancer: a hypothesis
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 516A Parran Hall, 130 DeSoto Street, Pittsburgh, PA 15261, USA
    Cancer Epidemiol Biomarkers Prev 14:2840-7. 2005
  7. ncbi Anthropometry and the risk of epithelial ovarian cancer
    Julia B Greer
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    Cancer 106:2247-57. 2006
  8. pmc Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy Trial
    Rachel H Mackey
    Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, 130 DeSoto Street, Pittsburgh, PA 15261, USA
    Cancer Epidemiol Biomarkers Prev 21:2022-32. 2012
  9. ncbi Peroxisome proliferator-activated receptor-gamma polymorphism, body mass and prostate cancer risk: evidence for gene-environment interaction
    Joseph M Zmuda
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Oncology 70:185-9. 2006
  10. ncbi Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures
    Katherine W Reeves
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 516A Parran Hall, 130 DeSoto Street, Pittsburgh, PA 15261, USA
    Cancer Epidemiol Biomarkers Prev 16:1468-73. 2007

Research Grants

  1. Molecular/Biologic/Genetic Mechanisms of Ovarian Cancer
    Francesmary Modugno; Fiscal Year: 2002
  2. Serum Markers of Breast /Ovarian Cancer Risk
    Francesmary Modugno; Fiscal Year: 2003
  3. Hormones, DNA Repair, BRCA1/2 and Ovarian Cancer Preven*
    Francesmary Modugno; Fiscal Year: 2003
  4. OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERS
    Francesmary Modugno; Fiscal Year: 2005
  5. The Role of Prolactin in Postmenopausal Breast Cancer
    Francesmary Modugno; Fiscal Year: 2005
  6. Ovarian Cancer: Prevention and Its Recurrence
    Francesmary Modugno; Fiscal Year: 2005

Detail Information

Publications44

  1. ncbi Association of estrogen receptor alpha polymorphisms with breast cancer risk in older Caucasian women
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Int J Cancer 116:984-91. 2005
    ..60 vs. 1.12 for nulliparous vs. parous women; interaction p = 0.03). ESR1 polymorphisms in combination with lifestyle factors may be associated with breast cancer risk in older Caucasian women...
  2. ncbi Estrogen metabolizing polymorphisms and breast cancer risk among older white women
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, PA, USA
    Breast Cancer Res Treat 93:261-70. 2005
    ..To investigate breast cancer risk according to metabolizing genes polymorphisms in older women...
  3. ncbi Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 516A Parran Hall, 130 DeSoto Street, Pittsburgh, PA 15261, USA
    Int J Cancer 118:1292-301. 2006
    ..Estrogen metabolism differs according to both BMI and HT use, potentially explaining the interaction between BMI and HT in relation to breast cancer risk...
  4. ncbi Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15261, USA
    Am J Obstet Gynecol 191:733-40. 2004
    ..We investigated whether the odds ratios for ovarian cancer that were associated with oral contraceptive use, childbearing, hysterectomy, and tubal ligation differ among women with and without endometriosis...
  5. ncbi Ovarian cancer and high-risk women-implications for prevention, screening, and early detection
    Francesmary Modugno
    Department of Epidemmiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Gynecol Oncol 91:15-31. 2003
    ....
  6. ncbi Inflammation and endometrial cancer: a hypothesis
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 516A Parran Hall, 130 DeSoto Street, Pittsburgh, PA 15261, USA
    Cancer Epidemiol Biomarkers Prev 14:2840-7. 2005
    ..A proinflammatory milieu can also directly increase estrogen production. Hence, inflammation may work in conjunction with or in addition to estrogen exposure in the development of endometrial cancer...
  7. ncbi Anthropometry and the risk of epithelial ovarian cancer
    Julia B Greer
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    Cancer 106:2247-57. 2006
    ..Because factors such as oral contraceptive (OC), hormone therapy (HT), and parity may affect weight and hormone levels, the associations were examined in women with and without these characteristics...
  8. pmc Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy Trial
    Rachel H Mackey
    Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, 130 DeSoto Street, Pittsburgh, PA 15261, USA
    Cancer Epidemiol Biomarkers Prev 21:2022-32. 2012
    ....
  9. ncbi Peroxisome proliferator-activated receptor-gamma polymorphism, body mass and prostate cancer risk: evidence for gene-environment interaction
    Joseph M Zmuda
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Oncology 70:185-9. 2006
    ..Peroxisome proliferator-activated receptor (PPAR)-gamma has been implicated in prostate cancer. In the present case-control study, we tested if a common Pro12Ala polymorphism in PPAR-gamma is associated with the risk of prostate cancer...
  10. ncbi Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures
    Katherine W Reeves
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 516A Parran Hall, 130 DeSoto Street, Pittsburgh, PA 15261, USA
    Cancer Epidemiol Biomarkers Prev 16:1468-73. 2007
    ..This study investigated the association between BMI and mortality after breast cancer diagnosis in a cohort of older Caucasian women enrolled in the Study of Osteoporotic Fractures...
  11. ncbi Short-term oral contraceptive use and the risk of epithelial ovarian cancer
    Julia B Greer
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA
    Am J Epidemiol 162:66-72. 2005
    ..Mediating factors may reflect endogenous hormone levels, OC metabolism, or OC bioactivity...
  12. doi Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women
    Alana G Hudson
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    Cancer Epidemiol Biomarkers Prev 17:680-7. 2008
    ..These cross-sectional findings suggest that NSAID use may be associated with lower circulating estradiol levels, potentially representing one mechanism through which NSAIDs exert protective effects on breast cancer...
  13. ncbi Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers
    Roberta B Ness
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Room 513 Parran Hall, 130 DeSoto Street, Pittsburgh, PA 15261, USA
    Eur J Cancer 42:691-703. 2006
    ..Moreover, treatments for endometriosis may require consideration of the impact on long-term cancer risk...
  14. pmc Development of a multimarker assay for early detection of ovarian cancer
    Zoya Yurkovetsky
    University of Pittsburgh Hillman Cancer Center, 5117 Centre Ave, Pittsburgh, PA 15213, USA
    J Clin Oncol 28:2159-66. 2010
    ..Early detection of ovarian cancer has great promise to improve clinical outcome...
  15. ncbi Breast cancer risk factors and mammographic breast density in women over age 70
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Breast Cancer Res Treat 97:157-66. 2006
    ..Breast density is a strong risk factor for breast cancer, but little is known about factors associated with breast density in women over 70...
  16. ncbi Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer
    Anna E Lokshin
    University of Pittsburgh Cancer Institute, Hillman Cancer Center, University of Pittsburgh, 5117 Centre Avenue, Pittsburgh, PA 15213, USA
    Gynecol Oncol 102:244-51. 2006
    ..The objective of this study was, therefore, to evaluate the potential importance of circulating anti-IL-8 antibody as ovarian cancer biomarker...
  17. ncbi Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma
    Anita S Y Sit
    Graduate School of Public Health, University of Pittsburgh, Pennsylvania 15213, USA
    Gynecol Oncol 86:118-23. 2002
    ..The aim of the study is to evaluate the impact of various HRT formulations and their characteristics of use on the risk of epithelial ovarian carcinoma (EOC)...
  18. ncbi Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer
    Carrie M Cottreau
    University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania 15261, USA
    Clin Cancer Res 9:5142-4. 2003
    ..The androgenic medication, danazol, and the antiandrogenic medications, leuprolide and nafarelin, are commonly used in the treatment of endometriosis. We assessed the associations between the use of these medications and ovarian cancer...
  19. ncbi Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review
    Francesmary Modugno
    Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Am J Epidemiol 159:319-35. 2004
    ..The sensitivity, specificity, positive and negative predictive values, and clinical validity of the PROGINS and AR CAG repeat assays are unknown. No recommendations for population-based screening can be made...
  20. ncbi Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis
    Chris Kahlenborn
    Department of Internal Medicine, Altoona Hospital, Altoona, PA, USA
    Mayo Clin Proc 81:1290-302. 2006
    ..To perform a meta-analysis of case-control studies that addressed whether prior oral contraceptive (OC) use is associated with premenopausal breast cancer...
  21. ncbi Reproductive factors and ovarian cancer risk in Jewish BRCA1 and BRCA2 mutation carriers (United States)
    Francesmary Modugno
    Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Cancer Causes Control 14:439-46. 2003
    ..To determine whether oral contraceptive (OC) use, childbearing, breastfeeding and tubal ligation differ between ovarian cancer cases with and without a BRCA1/2 mutation...
  22. ncbi Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure
    Anita S Y Sit
    Graduate School of Public Health, Magee Women s Hospital, University of Pittsburgh, Pennsylvania, USA
    Cancer Epidemiol Biomarkers Prev 13:1459-65. 2004
    ....
  23. doi Plasma leptin levels, LEPR Q223R polymorphism and mammographic breast density: a cross-sectional study
    Cher Dallal
    University of Pittsburgh, Department of Epidemiology, Graduate School of Public Health, Pittsburgh, PA, USA
    Int J Biol Markers 28:161-7. 2013
    ..03). These findings suggest that the association between leptin and breast density may vary by LEPR Q223R genotype, and that body mass index and leptin may act in an interactive way in determining breast density...
  24. ncbi Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer
    Julia B Greer
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA
    Obstet Gynecol 105:731-40. 2005
    ..The authors investigated whether OC efficacy might differ according to androgenicity by using data from a large, population-based, case-control study (the Steroid Hormones and Reproductions [SHARE] Study)...
  25. ncbi Gender of offspring and maternal ovarian cancer risk
    Gretchen L Gierach
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, University of Pittsburgh Cancer Institute, 3520 5th Avenue, Suite 510, Pittsburgh, PA 15213, USA
    Gynecol Oncol 101:476-80. 2006
    ..We sought to determine whether offspring gender, which differentially alters maternal hormonal milieu, may be associated with maternal ovarian cancer risk...
  26. ncbi Contribution of the prostate limits the usefulness of survivin for the detection of bladder cancer
    Benjamin Davies
    Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania 15232, USA
    J Urol 174:1767-70. 2005
    ..We determined if urinary survivin is influenced by the prostate and analyzed survivin levels in a healthy control population...
  27. ncbi Recreational physical activity and mammographic breast density characteristics
    Katherine W Reeves
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Suite 510, 3520 Fifth Avenue, Pittsburgh, PA 15213, USA
    Cancer Epidemiol Biomarkers Prev 16:934-42. 2007
    ..These results suggest that the mechanism by which physical activity reduces breast cancer risk may not involve breast density...
  28. pmc Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study
    Michelle L Kurta
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    Cancer Epidemiol Biomarkers Prev 21:1282-92. 2012
    ..We used data from a large case-control study to determine whether fertility drug use significantly impacts ovarian cancer risk when taking into account parity, gravidity, and cause of infertility...
  29. ncbi Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancer
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
    Obstet Gynecol 102:1336-43. 2003
    ..To examine alcohol consumption as a risk factor for epithelial ovarian cancer according to tumor histology...
  30. ncbi Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, 516A Parran Hall, 130 DeSoto Street, Pittsburgh, PA 15261, USA
    Epidemiology 13:467-71. 2002
    ..The association between cigarette smoking and ovarian cancer may vary according to the histologic type of tumor...
  31. ncbi Relations of gestational length and timing and type of incomplete pregnancy to ovarian cancer risk
    Gretchen L Gierach
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, USA
    Am J Epidemiol 161:452-61. 2005
    ..80, 95% CI: 0.44, 1.47). These data do not support an independent association between incomplete pregnancies, either spontaneous or induced, and ovarian cancer risk...
  32. ncbi Effect of raloxifene on sexual function in older postmenopausal women with osteoporosis
    Francesmary Modugno
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
    Obstet Gynecol 101:353-61. 2003
    ..To assess the effect of raloxifene compared with placebo on sexual function in older postmenopausal women undergoing therapy for the treatment of osteoporosis...
  33. ncbi Analysis of CHEK2 gene for ovarian cancer susceptibility
    Bora E Baysal
    Department of Obstetrics, Gynecology and Reproductive Sciences, The University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA
    Gynecol Oncol 95:62-9. 2004
    ..A deletion variant in the CHEK2 gene (del1100C) has been implicated as a low-penetrance risk factor for breast cancer. We sought to determine contribution of CHEK2 mutations to the etiology of ovarian cancer (OvCa)...
  34. pmc Ovarian cancer: prevention, detection, and treatment of the disease and its recurrence. Molecular mechanisms and personalized medicine meeting report
    Francesmary Modugno
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Int J Gynecol Cancer 22:S45-57. 2012
    ....
  35. ncbi A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis
    Francesmary Modugno
    Department of Epidemiology, University of Pittsburgh, PA 15261, USA
    Breast Cancer Res Treat 82:191-7. 2003
    ..The goals of this study are to identify CYPs expressed in breast tissue by measuring mRNA levels and to determine whether there are differences in mRNA levels between breast tumors and histologically-normal adjacent breast tissue...
  36. ncbi Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer
    Elieser Gorelik
    Department of Pathology and Immunology, University of Pittsburg School of Medicine and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA
    Cancer Epidemiol Biomarkers Prev 14:981-7. 2005
    ..5% sensitivity and 93.0% specificity. The presented data show that simultaneous testing of a panel of serum cytokines and CA-125 using LabMAP technology may present a promising approach for ovarian cancer detection...
  37. pmc Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium
    Martin Köbel
    Authors Affiliations Department of Pathology and Laboratory Medicine Department of Population Health Research, Alberta Health Services Cancer Care and Department of Medical Genetics, University of Calgary, Calgary, Alberta Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada Department of Medical Oncology Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology Division of Biomedical Statistics and Informatics, Department of Health Science Research Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology Division of Epidemiology, Department of Health Science Research, Mayo Clinic, Rochester, Minnesota Biostatistics and Informatics Shared Resource, University of Kansas Medical Center, Kansas City, Kansas University of Texas School of Public Health, Houston, Texas Roswell Park Cancer Institute, Buffalo, New York, New York Women s Cancer Research Center, Magee Womens Research Institute, University of Pittsburgh Cancer Institute Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania Gynaecological Cancer Research Centre, Women s Cancer, UCL EGA Institute for Women s Health Department of Pathology, Cancer Institute, UCL, London, United Kingdom and Department of Preventive Medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California
    Cancer Epidemiol Biomarkers Prev 22:1677-86. 2013
    ..Our aim was to evaluate histologic type assessments across the centers participating in the Ovarian Tumor Tissue Analysis (OTTA) consortium using an immunohistochemical (IHC) prediction model...
  38. doi Physical activity and mammographic density in a cohort of midlife women
    Nina Oestreicher
    Kaiser Permanente Division of Research, Oakland, CA 94612, USA
    Med Sci Sports Exerc 40:451-6. 2008
    ..Physical activity (PA) is one of few modifiable breast cancer risk factors. There have been few studies of the relation between PA and mammographic density, especially in multiethnic populations...
  39. doi Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women
    Anne McTiernan
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Breast Cancer Res Treat 108:217-31. 2008
    ..These results suggest that while age, oophorectomy status, and NSAID use may be associated with selected sex hormone concentrations, few menstrual or reproductive factors affect endogenous sex hormones in the postmenopausal period...
  40. ncbi Mammographic density in a multiethnic cohort
    Laurel A Habel
    Division of Research, Kaiser Permanente, Oakland, CA 94612, USA
    Menopause 14:891-9. 2007
    ..To compare mammographic density among premenopausal and early perimenopausal women from four racial/ethnic groups and to examine density and acculturation among Japanese and Chinese women...
  41. ncbi Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women
    Jun Wang
    Human Genetics Department, Roche Molecular Systems, Inc, 1145 Atlantic Ave, Alameda, CA 94555, USA
    Breast Cancer Res Treat 106:273-80. 2007
    ..001% in cases and controls). No other statistically significant associations were observed between ESR1 haplotypes from the same four SNPs and the risk of breast cancer in older Caucasian women...
  42. ncbi Relation of BMI and physical activity to sex hormones in postmenopausal women
    Anne McTiernan
    Fred Hutchinson Cancer Research Center, Division of Public Health Sciences, Cancer Prevention Research Program, Seattle, WA 98109, USA
    Obesity (Silver Spring) 14:1662-77. 2006
    ..However, the determinants of these hormone concentrations are not established. The purpose of this study was to examine correlates of endogenous sex hormones...
  43. ncbi Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer
    Simon A Gayther
    Translational Research Laboratories, University College London, London, United Kingdom
    Cancer Res 67:3027-35. 2007
    ..This study highlights the need for multicenter collaborations for genetic association studies...
  44. doi Oral contraceptives and breast cancer
    Chris Kahlenborn
    Holy Spirit Hospital Camp Hill, PA
    Mayo Clin Proc 83:849-50; author reply 850-1. 2008

Research Grants6

  1. Molecular/Biologic/Genetic Mechanisms of Ovarian Cancer
    Francesmary Modugno; Fiscal Year: 2002
    ..This workshop represents a unique opportunity to bring together scientist, policy researchers and consumer advocates to advance the frontier of ovarian cancer research and public health. ..
  2. Serum Markers of Breast /Ovarian Cancer Risk
    Francesmary Modugno; Fiscal Year: 2003
    ..We also expect to identify additional related research questions, which we anticipate studying further in a multi-center, collaborative fashion within the various arms of the WHI. ..
  3. Hormones, DNA Repair, BRCA1/2 and Ovarian Cancer Preven*
    Francesmary Modugno; Fiscal Year: 2003
    ..The expertise and data we will collect will promote future innovative research into understanding ovarian cancer. ..
  4. OVARIAN CANCER RISK AND SURVIVAL IN BRCA CARRIERS
    Francesmary Modugno; Fiscal Year: 2005
    ..Additionally, this training will provide the skills and experience needed to become an independent researcher in the molecular and genetic epidemiology of female cancers. ..
  5. The Role of Prolactin in Postmenopausal Breast Cancer
    Francesmary Modugno; Fiscal Year: 2005
    ..Approval for this study has already been obtained from SOF and we can begin the study as soon as funding is obtained. ..
  6. Ovarian Cancer: Prevention and Its Recurrence
    Francesmary Modugno; Fiscal Year: 2005
    ..This series represents a unique opportunity to bring together scientist, policy researchers and consumer advocates to advance the frontier of ovarian cancer research and public health. ..